Lead sponsor
Hvidovre University Hospital
9 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
9
Trials led
1
Active
281
Total enrollment
3
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2/3
4
Phase 3
1
Not applicable
4
Trials by status
Active, not recruiting
1
Completed
7
Unknown
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Semaglutide and Physical Activity for Obesity and MultimorbidityBMI ≥35not applicableActive, not recruiting35
Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 DiabetesBMI 18-27Ph 2/3Completed30
Influence of Gut Hormones on Food Intake After Roux-en-Y Gastric Bypass Surgery—not applicableCompleted12
Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With LiraglutideBMI ≥27not applicableCompleted9